The patients of type-2 diabetes would soon get a new long acting insulin shot. The new form of insulin would be given to the patents thrice-a-week rather than every day. The new insulin would be a breakthrough for the patients of type-2 diabetes. The body of these patients does not produce enough insulin which is required for the body to be able to use glucose for energy. The insulin injections are given to them so that their blood sugar level could be kept low. The newly developed insulin shot works for 48 hours and is as good in controlling the insulin as the once-a-day shot. The new form of long acting insulin, Degludec has been jointly tested by doctors from India, Canada, US and South Africa. The clinical trials of the new form of insulin suggest that it might help in reducing the risk of hypoglycemia.
Showing posts with label Insulin. Show all posts
Showing posts with label Insulin. Show all posts
Thursday, March 10, 2011
A New Long Acting Insulin for Diabetic Patients
The patients of type-2 diabetes would soon get a new long acting insulin shot. The new form of insulin would be given to the patents thrice-a-week rather than every day. The new insulin would be a breakthrough for the patients of type-2 diabetes. The body of these patients does not produce enough insulin which is required for the body to be able to use glucose for energy. The insulin injections are given to them so that their blood sugar level could be kept low. The newly developed insulin shot works for 48 hours and is as good in controlling the insulin as the once-a-day shot. The new form of long acting insulin, Degludec has been jointly tested by doctors from India, Canada, US and South Africa. The clinical trials of the new form of insulin suggest that it might help in reducing the risk of hypoglycemia.
Monday, October 29, 2007
Uma revolução para os diabéticos
Todos nós conhecemos pessoas que sofrem as agruras da diabetes, que vão desde alterações comportamentais inesperadas, até a dificuldades da visão. Mas, o que é mais doloroso, na perspectiva de um não - diabético, é a necessidade que um diabético tem de se picar diáriamente.
Parece que as agruras, pelo menos quanto à picada, estão a chegar ao fim, se não vejamos esta notícia revolucionária: o recente surgimento no mercado farmacêutico nacional de um inovador dispositivo de administração de insulina que apresenta como vantagem primacial a possibilidade de acabar com as muitas e incómodas injecções diárias a que aqueles pacientes, no caso de serem insulino-dependentes (os chamados diabéticos de tipo 1).
E que dispositivo é esse: O novo aparelho têm o tamanho de um “pager” e apenas 100 gramas de peso, e permite administrar, de forma permanente ao longo das 24 horas do dia, as doses de insulina necessárias a cada doente (de acordo com uma programação personalizada), monitorizando constantemente a evolução do tratamento e actuando em conformidade, difundindo mais ou menos quantidade do medicamento.
Felizmente, que a inovação tecnológica continua a melhorar a qualidade de vida das pessoas.
Subscribe to:
Posts (Atom)
